Mechanisms of Hela cell apoptosis induced by abnormal Savda Munziq total phenolics combined with chemotherapeutic agents

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 2, 2014, Pages 743-747

  Zhang, Yun Xia ^a   Abliz, Guzalnur ^a   Ye, Wei Jun ^b   Mutalipu, Zuohelaguli ^a   Li, Xiao Wen ^a   Wang, Hai Qin ^a   Buranjiang, Gulimire ^a   Upur, Halmurat ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Abnormal savda munziq total phenolics; Apoptosis; Bcl 2 gene; Hela cells; Survivin

Indexed keywords

ANTINEOPLASTIC AGENT; BIRC5 PROTEIN, HUMAN; CISPLATIN; DOCETAXEL; HERBACEOUS AGENT; INHIBITOR OF APOPTOSIS PROTEIN; MESSENGER RNA; PHENOL DERIVATIVE; PROTEIN BCL 2; TAXOID;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECT; FLOW CYTOMETRY; GENETICS; HELA CELL LINE; HUMAN; MEDICINAL PLANT; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CELL PROLIFERATION; CISPLATIN; DRUGS, CHINESE HERBAL; FLOW CYTOMETRY; HELA CELLS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; PHENOLS; PLANTS, MEDICINAL; PROTO-ONCOGENE PROTEINS C-BCL-2; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TAXOIDS;

EID: 84894645723     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.2.743     Document Type: Article

References (21)

1. Aikemu A, Umar A, Yusup A, et al (2012). Immunomodulatory and antitumour effects of abnormal Savda Munziq on S180 tumour-bearing mice. BMC Complement Altern Med, 12, 157.
2. Aikemu A, Yusup A, Umar A, et al (2012). The impact of the Uighur medicine abnormal savda munziq on antitumor and antioxidant activity in a S180 and Ehrlich ascites carcinoma mouse tumor model. Pharmacogn Mag, 8, 141-8.
3. Bergqvist M, Brattström D, Gullbo J, et al (2003). p53 status and its in vitro relationship to radiosensitivity and chemosensitivity in lung cancer. Anticancer Res, 23, 1207-12.
4. Chen D, Zheng X, Kang D, et al (2012). Apoptosis and expression of the Bcl-2 family of proteins and P53 in human pancreatic ductal adenocarcinoma. Med Princ Pract, 21, 68-73.
5. Chen KY, Tangnur A, Wang GN, Guzalnur A (2011). The effect of total phenolics from abnormal savda munziq on cervical cancer cell lines. J Chin Med Mater, 34, 1255-9.
6. Chen ZY, Liang K, Qiu RX (2010). Targeted gene delivery in tumor xenografts by the combination of ultrasound-targeted microbubble destruction and polyethylenimine to inhibit survivin gene expression and induce apoptosis. J Exp Clin Cancer Res, 29, 152.
7. Chen ZY, Liang K, Lin Y, Yang F (2013). Study of the UTMD-Based Delivery System to Induce Cervical Cancer Cell Apoptosis and Inhibit Proliferation with shRNA targeting Survivin. Int J Mol Sci, 14, 1763-77.
8. Gan XL, Li JK, Yu TH, Zhang Y, Hu LN (2011). High expressions of bcl-2 and survivin, and decreased apoptosis in uterine cervical carcinosarcoma compared to cervical squamous cell carcinoma. Arch Gynecol Obstet, 284, 175-81.
9. Gupta RK, Banerjee A, Pathak S, Sharma C, Singh N (2013). Induction of mitochondrial-mediated apoptosis by Morinda citrifolia (Noni) in human cervical cancer cells. Asian Pac J Cancer Prev, 14, 237-42.
10. Ke QH, Zhou SQ, Du W, et al (2012). Early efficacy of taxotere and cisplatin chemo-radiotherapy for advanced cervical cancer. Asian Pac J Cancer Prev, 13, 617-9,.
11. Kizaibek M, Popescu R, Prinz S, et al (2012). Towards modernization of the formulation of the traditional Uighur medicine herbal preparation abnormal Savda munziq. Evid Based Complement Alternat Med, 2012, 863101,.
12. O'Connor S, Szwej E, Nikodinovic-Runic J, et al (2013). The anti-cancer activity of a cationic anti-microbial peptide derived from monomers of polyhydroxyalkanoate. Biomaterials, 34, 2710-8.
13. Pu J, Qin SS, Ding JX, et al (2013). A randomized controlled study of single-agent cisplatin and radiotherapy versus docetaxel/cisplatin and radiotherapy in high-risk early-stage cervical cancer after radical surgery. J Cancer Res Clin Oncol, 139, 703-8.
14. Pu J, Qin SS, Ding JX, et al (2013). A randomized controlled study of single-agent cisplatin and radiotherapy versus docetaxel/cisplatin and radiotherapy in high-risk early-stage cervical cancer after radical surgery. Cancer Res Clin Oncol, 139, 703-8.
15. Upur H, Yusup A, Baudrimont I, et al (2011). Inhibition of Cell Growth and Cellular Protein, DNA and RNA Synthesis in Human Hepatoma (HepG2) Cells by Ethanol Extract of Abnormal Savda Munziq of Traditional Uighur Medicine. Evid Based Complement Alternat Med, 2011, 251424.
16. Vidya Priyadarsini R, Senthil Murugan R, Maitreyi S, et al (2010). The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-κB inhibition. Eur J Pharmacol, 649, 84-91,.
17. Wang S, Zhang DS, Pan T, Liu S, Wang MK (2010). Efficacy of concurrent chemoradiotherapy plus adjuvant chemotherapy on advanced cervical cancer. Chin J Cancer, 29, 959-63.
18. Wu SF, Zhang JW, Qian WY, et al (2012). Altered expression of survivin, Fas and FasL contributed to cervical cancer development and metastasis. Eur Rev Med Pharmacol Sci, 16, 2044-50.
19. Yusup A, Upur H, Baudrimont I, et al (2005). Cytotoxicity of abnormal Savda Munziq aqueous extract in human hepatoma (HepG2) cells. Fundam Clin Pharmacol, 19, 465-72.
20. Yusup A, Upur H, Umar A, Berke B, Moore N (2012). Ethanol Extract of Abnormal Savda Munziq, a Herbal Preparation of Traditional Uighur Medicine, Inhibits Caco-2 Cells Proliferation via Cell Cycle Arrest and Apoptosis. Evid Based Complement Alternat Med, 2012, 926329.
21. Yusup A, Upur H, Umar A, et al (2011). Abnormal Savda Munziq, an Herbal Preparation of Traditional Uighur Medicine, May Prevent 1,2-dimethylhydrazine-Induced Rat Colon Carcinogenesis. Evid Based Complement Alternat Med, 2011, 152015.